The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.
【저자키워드】 SARS-CoV-2, Novel coronavirus, COVID 19, heart failure, Cardiomyopathy, 【초록키워드】 COVID-19, coronavirus disease, coronavirus, Genetic, Infection, myocardial injury, myocarditis, disease, association, Inflammatory response, COVID-19 patient, Cardiac complications, dysfunction, cardiovascular complication, acute respiratory syndrome, Myocardium, increased risk, individual, severe symptoms, heterogeneous group, myocardial involvement, shown, occur, variety, cause, electrical, ventricular, 【제목키워드】 review, Complication, cardiac,